Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Regular U-500 Insulin TID vs BID in T2DM
NCT01774968Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2013
- Primary completion
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Feb 2013; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01774968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01774968.